Menu

A+ A A-

Download article

Yanchenko V.V., Velichinskaya O.G.
Changes of the cellular and humoral immunity in patients with cold and chronic spontaneous urticaria
Education Establishment "Vitebsk State Order of Peoples’ Friendship Medical University", Republic of Belarus

Abstract.
Objectives. To estimate the condition of the cellular and humoral link of the immune system in patients with cold  and chronic spontaneous urticaria.
Material and methods. 126 patients of the allergological department of Vitebsk regional clinical hospital participated in the research: 47 patients with cold urticaria at the age of 47,0 (38,0-52,0) years and 79 persons aged 43,0 (28,0-51,0) with chronic spontaneous urticaria. The control group consisted of 38 healthy volunteers at the age of 42,5 (34,5-54,0) years. The research program has been approved by the ethics committee. In all patients prior to the beginning of their treatment on an empty stomach samples of blood were taken to determine the quantity and phenotype of leukocytes, the level of immunoglobulins. Phenotyping of the cells was conducted with the help of monoclonal antibodies CD19, CD23, CD3, CD4, CD25, CD8, CD69, CD203с (complex test systems for scientific and clinical researches «Bioskan-M1») using Cytomics FC 500 (Beckman Coulter Inc., the USA) cytometer.
Results. The immune status of patients with cold urticaria in the exacerbation period was characterised by the decrease in the absolute quantity of CD3+ and CD4+CD25+ lymphocytes of the peripheral blood. The immune status of the patients with chronic spontaneous urticaria in the exacerbation period was characterised by the decrease in the absolute quantity of CD4+CD25+ lymphocytes of the peripheral blood, the increase of the relative amount of CD19+CD23+ lymphocytes of the peripheral blood and the increase of the absolute quantity of CD203с of positive basophils. In patients with chronic spontaneous urticaria immunoglobulin M was within the limits of the population norm, but its concentration was higher than that in the group of healthy people.
Conclusion. In patients with cold and chronic spontaneous urticaria in the exacerbation period of the disease the high degree deficiency of CD4+CD25+ lymphocytes taking part in the development of both types of urticaria was revealed.
Key words: cold urticaria, chronic spontaneous urticaria, immune status.

References

1. Jain, S. Pathogenesis of chronic urticaria: an overview [Electronic resource]. Dermatol Res Pract. 2014. Mode of access: http://dx.doi.org/10.1155/2014/674709. Date of access: 02.12.2014.
2. Grattan CEH. Basophils in Chronic Urticaria. J of Investigative Dermatology Symposium Proceedings. 2001;6:139-40.
3. Lieberman PL, Blaiss MS. Atlas of Allergic Diseases. Philadelphi: Current Medicine; 2002. 274 p.
4. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008 Mar;8(3):205-17.
5. Bühring HJ, Streble A, Valent P. The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol. 2004 Apr;133(4):317-29.
6. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, Harbeck RJ. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006 Jun;117(6):1430-4.
7.Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr;35(4):456-60.
8. Ye YM, Yang EM, Yoo HS, Shin YS, Kim SH, Park HS. Increased Level of Basophil CD203c Expression Predicts Severe Chronic Urticaria. J Korean Med Sci. 2014 Jan;29(1):43-7.
9. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008 Jul;454(7203):445-54.
10. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol. 2005 Nov;116(5):961-8.
11. Belova OV, Arion VIa, Sergienko VI. Rol' tsitokinov v immunologicheskoi funktsii kozhi [Role of cytokines in immunologic function of a skin]. Immunologiia, allergologiia, infektologiia. 2008;(1):41-55.
12. Rabenhorst A, Hartmann K. Interleukin-31: a novel diagnostic marker of allergic diseases. Curr Allergy Asthma Rep. 2014 Apr;14(4):423.
13. Novikov DK, Novikov PD, Vykhristenko LR, Titova ND. Allergicheskie bolezni [Allergic illnesses]: posobie. Vitebsk, RB: VGMU; 2012. 204 р.
14. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW,  Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014 Jul;69(7):868-87.
15. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, Mirakian R, Walker SM, Huber PA, Nasser SM. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007 May;37(5):631-50.
16. Gushchin IS, red. Rossiiskii natsional'nyi soglasitel'nyi dokument «Krapivnitsa i angiootek» [Russian national conciliatory document «Urticaria and Angiootek»]: rek. dlia prakt. vrachei. Moscow, RF: Farmfrus Print Media; 2007. 128 р.
17. Gordon A. Vaccines and vaccination. N Engl J Med. 2001;345:1042-53.
18.Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008 Mar;8(3):205-17.
19. Arshi S, Babaie D, Nabavi M, Tebianian M, Ghalehbaghi B, Jalali F, Ahmadvand A, Gholami R. Circulating level of CD4+CD25+FOXP3+ T cells in patients with chronic urticaria. Int J Dermatol. 2014 Oct;53(12):561-6.
20. Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr;35(4):456-60.

Поиск по сайту